{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,11,19]],"date-time":"2026-11-19T12:05:22Z","timestamp":1795089922937,"version":"4.10.2"},"reference-count":40,"publisher":"Ovid Technologies (Wolters Kluwer Health)","issue":"4","content-domain":{"domain":["lww.com","ovid.com"],"crossmark-restriction":true},"short-container-title":[],"published-print":{"date-parts":[[2021,4]]},"abstract":"<jats:p>Mesonephric adenocarcinoma (MA) and mesonephric-like adenocarcinoma (MLA) are uncommon neoplasms of the gynecologic tract that have until recently been poorly understood. Although their morphologic, immunohistochemical, and molecular profiles have been recently defined, little is known about their clinical behavior. Small studies have demonstrated inconsistent findings and no large studies have examined the clinical behavior of these adenocarcinomas. In this multi-institutional study, representing the largest and most stringently defined cohort of cases to date, we examined the clinicopathologic features of 99 MAs and MLAs (30 MAs of the uterine cervix, 44 MLAs of the endometrium, and 25 MLAs of the ovary). Only tumors with characteristic mesonephric morphology and either immunohistochemical or molecular support were included. Our results demonstrate that the majority of mesonephric neoplasms presented at an advanced stage (II to IV) (15\/25 [60%] MA of the cervix, 25\/43 [58%] MLA of the endometrium, and 7\/18 [39%] MLA of the ovary). The majority (46\/89 [52%] overall, 12\/24 [50%] MA of the cervix, 24\/41 [59%] MLA of the endometrium, and 10\/24 [42%] MLA of the ovary) developed recurrences, most commonly distant (9\/12 [75%] MA of the cervix, 22\/24 [92%] MLA of the endometrium, and 5\/9 [56%] MLA of the ovary). The 5-year disease-specific survival was 74% (n=26) for MA of cervix, 72% (n=43) for MLA of endometrium, and 71% (n=23) for MLA of ovary. Our results confirm that mesonephric neoplasms are a clinically aggressive group of gynecologic carcinomas that typically present at an advanced stage, with a predilection for pulmonary recurrence.<\/jats:p>","DOI":"10.1097\/pas.0000000000001612","type":"journal-article","created":{"date-parts":[[2020,11,8]],"date-time":"2020-11-08T21:01:29Z","timestamp":1604869289000},"page":"498-506","update-policy":"https:\/\/doi.org\/10.1097\/lww.0000000000001000","source":"Crossref","is-referenced-by-count":151,"title":["Clinicopathologic Characteristics of Mesonephric Adenocarcinomas and Mesonephric-like Adenocarcinomas in the Gynecologic Tract"],"prefix":"10.1097","volume":"45","author":[{"given":"Jennifer","family":"Pors","sequence":"first","affiliation":[{"name":"Department of Pathology and Laboratory Medicine, Vancouver General Hospital and University of British Columbia"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Sheila","family":"Segura","sequence":"additional","affiliation":[{"name":"Department of Pathology, Memorial Sloan Kettering Cancer Center, New York, NY"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Derek S.","family":"Chiu","sequence":"additional","affiliation":[{"name":"BC Cancer Agency"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Noorah","family":"Almadani","sequence":"additional","affiliation":[{"name":"Department of Pathology and Laboratory Medicine, Vancouver General Hospital and University of British Columbia"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Hezhen","family":"Ren","sequence":"additional","affiliation":[{"name":"Department of Pathology and Laboratory Medicine, Vancouver General Hospital and University of British Columbia"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Daniel J.","family":"Fix","sequence":"additional","affiliation":[{"name":"Department of Pathology, Memorial Sloan Kettering Cancer Center, New York, NY"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Brooke E.","family":"Howitt","sequence":"additional","affiliation":[{"name":"Department of Pathology, Stanford University School of Medicine, Palo Alto, CA"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"David","family":"Kolin","sequence":"additional","affiliation":[{"name":"Department of Pathology, Brigham and Women\u2019s Hospital, Boston, MA"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"W. Glenn","family":"McCluggage","sequence":"additional","affiliation":[{"name":"Department of Pathology, Belfast Health and Social Care Trust, Belfast, Northern Ireland, UK"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Jelena","family":"Mirkovic","sequence":"additional","affiliation":[{"name":"Department of Pathology, Sunnybrook Health Sciences Centre, Toronto, ON, Canada"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Blake","family":"Gilks","sequence":"additional","affiliation":[{"name":"Department of Pathology and Laboratory Medicine, Vancouver General Hospital and University of British Columbia"},{"name":"Genetic Pathology Evaluation Center, Vancouver, BC"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Kay J.","family":"Park","sequence":"additional","affiliation":[{"name":"Department of Pathology, Memorial Sloan Kettering Cancer Center, New York, NY"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Lynn","family":"Hoang","sequence":"additional","affiliation":[{"name":"Department of Pathology and Laboratory Medicine, Vancouver General Hospital and University of British Columbia"},{"name":"Genetic Pathology Evaluation Center, Vancouver, BC"}],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"276","published-online":{"date-parts":[[2020,11,5]]},"reference":[{"key":"R1-20250608","doi-asserted-by":"crossref","first-page":"1013","DOI":"10.1111\/his.12895","article-title":"Hormone receptor-negative, thyroid transcription factor 1-positive uterine and ovarian adenocarcinomas: report of a series of mesonephric-like adenocarcinomas","volume":"68","author":"McFarland","year":"2016","journal-title":"Histopathology"},{"key":"R2-20250608","doi-asserted-by":"crossref","first-page":"1158","DOI":"10.1097\/00000478-199510000-00006","article-title":"Malignant mesonephric neoplasms of the uterine cervix. A report of eight cases, including four with a malignant spindle cell component","volume":"19","author":"Clement","year":"1995","journal-title":"Am J Surg Pathol"},{"key":"R3-20250608","doi-asserted-by":"crossref","first-page":"12","DOI":"10.1097\/PAS.0000000000000991","article-title":"Clinicopathologic and molecular characteristics of mesonephric adenocarcinoma arising from the uterine body","volume":"43","author":"Na","year":"2019","journal-title":"Am J Surg Pathol"},{"key":"R4-20250608","doi-asserted-by":"crossref","first-page":"7","DOI":"10.1016\/j.gore.2016.05.002","article-title":"Mesonephric adenocarcinoma of the cervix: case report and literature review","volume":"17","author":"Dierickx","year":"2016","journal-title":"Gynecol Oncol Rep"},{"key":"R5-20250608","doi-asserted-by":"crossref","first-page":"389","DOI":"10.1097\/PAS.0000000000001193","article-title":"A combined morphologic and molecular approach to retrospectively identify kras-mutated mesonephric-like adenocarcinomas of the endometrium","volume":"43","author":"Kolin","year":"2018","journal-title":"Am J Surg Pathol"},{"key":"R6-20250608","doi-asserted-by":"crossref","first-page":"1100","DOI":"10.1097\/00000478-199012000-00002","article-title":"Mesonephric remnants, hyperplasia, and neoplasia in the uterine cervix. A study of 49 cases","volume":"14","author":"Ferry","year":"1990","journal-title":"Am J Surg Pathol"},{"key":"R7-20250608","doi-asserted-by":"crossref","first-page":"1411","DOI":"10.1097\/PAS.0000000000000471","article-title":"GATA3 is a sensitive and specific marker of benign and malignant mesonephric lesions in the lower female genital tract","volume":"39","author":"Howitt","year":"2015","journal-title":"Am J Surg Pathol"},{"key":"R8-20250608","doi-asserted-by":"crossref","first-page":"1596","DOI":"10.1097\/PAS.0000000000001142","article-title":"A comparison of GATA3, TTF1, CD10, and calretinin in identifying mesonephric and mesonephric-like carcinomas of the gynecologic tract","volume":"42","author":"Pors","year":"2018","journal-title":"Am J Surg Pathol"},{"key":"R9-20250608","doi-asserted-by":"crossref","first-page":"799","DOI":"10.1097\/PAS.0b013e31824a72c6","article-title":"Mesonephric adenocarcinomas of the uterine cervix and corpus: HPV-negative neoplasms that are commonly PAX8, CA125, and HMGA2 positive and that may be immunoreactive with TTF1 and hepatocyte nuclear factor 1-\u03b2","volume":"36","author":"Kenny","year":"2012","journal-title":"Am J Surg Pathol"},{"key":"R10-20250608","doi-asserted-by":"crossref","first-page":"1504","DOI":"10.1038\/modpathol.2015.103","article-title":"Targeted genomic profiling reveals recurrent KRAS mutations and gain of chromosome 1q in mesonephric carcinomas of the female genital tract","volume":"28","author":"Mirkovic","year":"2015","journal-title":"Mod Pathol"},{"key":"R11-20250608","doi-asserted-by":"crossref","first-page":"495","DOI":"10.1097\/PAS.0000000000001403","article-title":"c-KIT analysis and targeted molecular sequencing of mesonephric carcinomas of the female genital tract","volume":"44","author":"Pors","year":"2019","journal-title":"Am J Surg Pathol"},{"key":"R12-20250608","doi-asserted-by":"crossref","first-page":"448","DOI":"10.1097\/PGP.0000000000000444","article-title":"An ovarian adenocarcinoma with combined low-grade serous and mesonephric morphologies suggests a M\u00fcllerian origin for some mesonephric carcinomas","volume":"37","author":"Chapel","year":"2018","journal-title":"Int J Gynecol Pathol"},{"key":"R13-20250608","doi-asserted-by":"crossref","first-page":"227","DOI":"10.1097\/PAS.0000000000000958","article-title":"Targeted genomic profiling reveals recurrent KRAS mutations in mesonephric-like adenocarcinomas of the female genital tract","volume":"42","author":"Mirkovic","year":"2018","journal-title":"Am J Surg Pathol"},{"key":"R14-20250608","doi-asserted-by":"crossref","first-page":"251","DOI":"10.1016\/j.jmoldx.2014.12.006","article-title":"Memorial Sloan Kettering-Integrated Mutation Profiling of Actionable Cancer Targets (MSK-IMPACT): a hybridization capture-based next-generation sequencing clinical assay for solid tumor molecular oncology","volume":"17","author":"Cheng","year":"2015","journal-title":"J Mol Diagn"},{"key":"R15-20250608","doi-asserted-by":"crossref","first-page":"751","DOI":"10.5858\/arpa.2016-0527-OA","article-title":"Validation of OncoPanel: a targeted next-generation sequencing assay for the detection of somatic variants in cancer","volume":"141","author":"Garcia","year":"2017","journal-title":"Arch Pathol Lab Med"},{"key":"R17-20250608","doi-asserted-by":"crossref","first-page":"bcr0120125632","DOI":"10.1136\/bcr.01.2012.5632","article-title":"Mesonephric adenocarcinoma of the uterine cervix and literature review","volume":"2012","author":"Anagnostopoulos","year":"2012","journal-title":"BMJ Case Rep"},{"key":"R18-20250608","doi-asserted-by":"crossref","first-page":"327","DOI":"10.1097\/00004347-200210000-00003","article-title":"Symposium part II: special types of adenocarcinoma of the uterine cervix","volume":"21","author":"Hart","year":"2002","journal-title":"Int J Gynecol Pathol"},{"key":"R19-20250608","doi-asserted-by":"crossref","first-page":"54","DOI":"10.1186\/s13000-019-0830-4","article-title":"Coexistence of endometrial mesonephric-like adenocarcinoma and endometrioid carcinoma suggests a M\u00fcllerian duct lineage: a case report","volume":"14","author":"Yano","year":"2019","journal-title":"Diagn Pathol"},{"key":"R20-20250608","doi-asserted-by":"crossref","first-page":"84","DOI":"10.1097\/PGP.0000000000000573","article-title":"Ovarian combined low-grade serous and mesonephric-like adenocarcinoma: further evidence for a Mullerian origin of mesonephric-like adenocarcinoma","volume":"39","author":"McCluggage","year":"2020","journal-title":"Int J Gynecol Pathol"},{"key":"R21-20250608","doi-asserted-by":"crossref","first-page":"1405","DOI":"10.1002\/1097-0142(196709)20:9<1405::AID-CNCR2820200907>3.0.CO;2-B","article-title":"\u201cMesonephroma\u201d of ovary. Tumor of M\u00fcllerian nature related to the endometrioid carcinoma","volume":"20","author":"Scully","year":"1967","journal-title":"Cancer"},{"key":"R22-20250608","first-page":"1","article-title":"Mesonephroma ovarii","volume":"35","author":"Schiller","year":"1939","journal-title":"Am J Cancer"},{"key":"R23-20250608","doi-asserted-by":"crossref","first-page":"745","DOI":"10.1002\/1097-0142(197004)25:4<745::AID-CNCR2820250402>3.0.CO;2-2","article-title":"Adenocarcinoma of the vagina in adolescence. A report of 7 cases including 6 clear-cell carcinomas (so-called mesonephromas)","volume":"25","author":"Herbst","year":"1970","journal-title":"Cancer"},{"key":"R24-20250608","doi-asserted-by":"crossref","first-page":"840","DOI":"10.1111\/his.12332","article-title":"Thyroid transcription factor-1 (TTF-1) immunoreactivity is an adverse prognostic factor in endometrioid adenocarcinoma of the uterine corpus","volume":"64","author":"Ervine","year":"2014","journal-title":"Histopathology"},{"key":"R25-20250608","doi-asserted-by":"crossref","first-page":"271","DOI":"10.1007\/s00428-002-0752-4","article-title":"Immunoprofile of cervical and endometrial adenocarcinomas using a tissue microarray","volume":"442","author":"Alkushi","year":"2003","journal-title":"Virchows Arch"},{"key":"R26-20250608","doi-asserted-by":"crossref","first-page":"1759","DOI":"10.1097\/PAS.0b013e3181131e21","article-title":"Thyroid transcription factor-1 expression in endometrial and endocervical adenocarcinomas","volume":"31","author":"Siami","year":"2007","journal-title":"Am J Surg Pathol"},{"key":"R27-20250608","doi-asserted-by":"crossref","first-page":"317","DOI":"10.1007\/s00404-009-1115-z","article-title":"Five commonly used markers (p53, TTF1, CK7, CK20, and CK34betaE12) are of no use in distinguishing between primary endocervical and endometrial adenocarcinomas in a tissue microarray extension study","volume":"281","author":"Han","year":"2010","journal-title":"Arch Gynecol Obstet"},{"key":"R28-20250608","doi-asserted-by":"crossref","first-page":"195","DOI":"10.1111\/his.12383","article-title":"Napsin A is a useful marker for metastatic adenocarcinomas of pulmonary origin","volume":"65","author":"Kim","year":"2014","journal-title":"Histopathology"},{"key":"R29-20250608","doi-asserted-by":"crossref","first-page":"957","DOI":"10.1016\/j.humpath.2015.03.008","article-title":"Napsin A is frequently expressed in clear cell carcinoma of the ovary and endometrium","volume":"46","author":"Iwamoto","year":"2015","journal-title":"Hum Pathol"},{"key":"R30-20250608","doi-asserted-by":"crossref","first-page":"971","DOI":"10.1007\/s00432-019-03123-7","article-title":"Mesonephric-like adenocarcinomas of the uterine corpus: report of a case series and review of the literature indicating poor prognosis for this subtype of endometrial adenocarcinoma","volume":"146","author":"Horn","year":"2020","journal-title":"J Cancer Res Clin Oncol"},{"key":"R31-20250608","doi-asserted-by":"crossref","first-page":"458","DOI":"10.1016\/S0090-8258(03)00228-2","article-title":"Activity of chemotherapy with carboplatin plus paclitaxel in a recurrent mesonephric adenocarcinoma of the uterine corpus","volume":"90","author":"Montagut","year":"2003","journal-title":"Gynecol Oncol"},{"key":"R32-20250608","doi-asserted-by":"crossref","first-page":"129","DOI":"10.1111\/j.1365-2303.2012.00959.x","article-title":"Cytopathology of cervical mesonephric adenocarcinoma: a report of two cases","volume":"24","author":"Nomoto","year":"2013","journal-title":"Cytopathology"},{"key":"R33-20250608","doi-asserted-by":"crossref","first-page":"71","DOI":"10.1186\/s13000-019-0847-8","article-title":"Mesonephric adenocarcinoma of the cervix: a case report with a three-year follow-up, lung metastases, and next-generation sequencing analysis","volume":"14","author":"Montalvo","year":"2019","journal-title":"Diagn Pathol"},{"key":"R34-20250608","doi-asserted-by":"crossref","first-page":"429","DOI":"10.1097\/PAS.0000000000001401","article-title":"Mesonephric-like carcinoma of the endometrium: a subset of endometrial carcinoma with an aggressive behavior","volume":"44","author":"Euscher","year":"2020","journal-title":"Am J Surg Pathol"},{"key":"R35-20250608","doi-asserted-by":"crossref","first-page":"270","DOI":"10.3802\/jgo.2015.26.4.270","article-title":"Pulmonary metastasectomy in uterine malignancy: outcomes and prognostic factors","volume":"26","author":"Paik","year":"2015","journal-title":"J Gynecol Oncol"},{"key":"R36-20250608","first-page":"65","article-title":"FIGO Stage I endometrial carcinoma: evaluation of lung metastases and follow-up","volume":"29","author":"Labi","year":"2008","journal-title":"Eur J Gynaecol Oncol"},{"key":"R37-20250608","doi-asserted-by":"crossref","first-page":"266","DOI":"10.4143\/crt.2014.206","article-title":"A clinicopathological review of pulmonary metastasis from uterine cervical cancer","volume":"48","author":"Ki","year":"2016","journal-title":"Cancer Res Treat"},{"key":"R38-20250608","doi-asserted-by":"crossref","first-page":"1449","DOI":"10.1097\/PAS.0000000000000532","article-title":"Gastric type endocervical adenocarcinoma: an aggressive tumor with unusual metastatic patterns and poor prognosis","volume":"39","author":"Karamurzin","year":"2015","journal-title":"Am J Surg Pathol"},{"key":"R39-20250608","doi-asserted-by":"crossref","first-page":"664","DOI":"10.1097\/01.pas.0000213434.91868.b0","article-title":"Gastric morphology and immunophenotype predict poor outcome in mucinous adenocarcinoma of the uterine cervix","volume":"31","author":"Kojima","year":"2007","journal-title":"Am J Surg Pathol"},{"key":"R40-20250608","doi-asserted-by":"crossref","first-page":"760","DOI":"10.1016\/j.ygyno.2014.01.012","article-title":"Comparison of clinical outcomes of patients with clear cell and endometrioid ovarian cancer associated with endometriosis to papillary serous carcinoma of the ovary","volume":"132","author":"Davis","year":"2014","journal-title":"Gynecol Oncol"},{"key":"R41-20250608","doi-asserted-by":"crossref","first-page":"802","DOI":"10.1002\/cncr.30496","article-title":"Confirmation of ProMisE: a simple, genomics-based clinical classifier for endometrial cancer","volume":"123","author":"Talhouk","year":"2017","journal-title":"Cancer"}],"container-title":["American Journal of Surgical Pathology"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/journals.lww.com\/10.1097\/PAS.0000000000001612","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2025,6,8]],"date-time":"2025-06-08T22:01:53Z","timestamp":1749420113000},"score":1,"resource":{"primary":{"URL":"https:\/\/journals.lww.com\/10.1097\/PAS.0000000000001612"}},"subtitle":["A Multi-institutional Study"],"short-title":[],"issued":{"date-parts":[[2020,11,5]]},"references-count":40,"journal-issue":{"issue":"4","published-print":{"date-parts":[[2021]]}},"URL":"https:\/\/doi.org\/10.1097\/pas.0000000000001612","relation":{},"ISSN":["0147-5185"],"issn-type":[{"value":"0147-5185","type":"print"}],"subject":[],"published":{"date-parts":[[2020,11,5]]}}}